|
 |
 |
Brian Feagan, MD
Director, Robarts Research
Institute
Professor of Medicine
Professor of Epidemiology
and Biostatistics
University of Western Ontario
London Health Sciences Centre
London, ON
Canada |
|
|
New Biologics in the Treatment of Crohn's Disease —William Sandborn, MD, Executive Editor |
| Part 1: |
Advances in Treatment with New Biologics —Stephen Hanauer, MD - for reference only, not for CME credit |
Download PDF |
| Part 2: |
New Targets for Disease Modification: Anti-Alpha4 Integrin Therapy —William Sandborn, MD - for reference only, not for CME credit |
Download
PDF |
| Part 3: |
Maximizing Outcomes in Crohn's Disease —Brian Feagan, MD - for reference only, not for CME credit |
Download
PDF |
 |
|
| |
|
|